EGenesis Announces Publication in Nature Communications
We are excited to announce the publication of a paper in Nature Communications by EGenesis, a leading company in the field of xenotransplantation. The paper, titled “Long-term survival of porcine kidney grafts in non-human primates,” describes the successful transplantation of porcine kidneys into non-human primates. The kidneys functioned well for up to 9 months, and the primates showed no signs of rejection.
This is a significant breakthrough in the field of xenotransplantation, and it has the potential to revolutionize the way we treat kidney failure. Currently, there are over 100,000 people in the United States waiting for a kidney transplant, and the average wait time is over 3 years. Xenotransplantation could provide a much-needed alternative for these patients.
EGenesis is a leading company in the field of xenotransplantation, and they have a strong track record of success. They have already successfully transplanted porcine hearts, lungs, and pancreases into non-human primates. We believe that EGenesis is well-positioned to bring xenotransplantation to the clinic, and we are excited to be a part of their journey.
If you are interested in learning more about xenotransplantation, we encourage you to visit the EGenesis website. You can also sign up for our newsletter to stay up-to-date on the latest developments in the field.
